| 1 |
34204596 | Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer. | 2021 Jun 12 |
1 |
| 2 |
30775247 | Current strategies for targeting the activity of androgen receptor variants. | 2019 Jan |
2 |
| 3 |
30083960 | Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer. | 2018 Dec |
1 |
| 4 |
28049163 | Correction: Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer. | 2017 Jan 1 |
1 |
| 5 |
28500234 | Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. | 2017 Aug |
3 |
| 6 |
27049719 | Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer. | 2016 May 31 |
1 |
| 7 |
28642838 | Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer. | 2016 Oct |
1 |
| 8 |
24740322 | Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer. | 2014 Jun 15 |
3 |